Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tom N. Hoel, Amrit Singh Thiara, Vibeke Videm, Arnt E. Fiane, Tom E. Mollnes, Albert Castellheim & Jan L. Svennevig. (2009) In vitro evaluation of PHISIO-coated sets for pediatric cardiac surgery. Scandinavian Cardiovascular Journal 43:2, pages 129-135.
Read now
Read now
Articles from other publishers (23)
Nicholas D. Andersen, James M. Meza & Joseph W. Turek. 2023. Pediatric Cardiac Surgery. Pediatric Cardiac Surgery
161
189
.
Kristina N. Ekdahl, Inga Soveri, Jöns Hilborn, Bengt Fellström & Bo Nilsson. (2017) Cardiovascular disease in haemodialysis: role of the intravascular innate immune system. Nature Reviews Nephrology 13:5, pages 285-296.
Crossref
Crossref
Reindert W. Emmens, Diana Wouters, Sacha Zeerleder, S. Marieke van Ham, Hans W.M. Niessen & Paul A.J. Krijnen. (2017) On the value of therapeutic interventions targeting the complement system in acute myocardial infarction. Translational Research 182, pages 103-122.
Crossref
Crossref
Sarah Mousavi, Mandana Moradi, Tina Khorshidahmad & Maryam Motamedi. (2015) Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review. Advances in Pharmacological Sciences 2015, pages 1-14.
Crossref
Crossref
Darryl H. Berkowitz & J. William Gaynor. 2012. Pediatric Cardiac Surgery. Pediatric Cardiac Surgery
169
213
.
I. Dimarakis, V. Joshi, W. Hesford & G. Asimakopoulos. 2012. Minimized Cardiopulmonary Bypass Techniques and Technologies. Minimized Cardiopulmonary Bypass Techniques and Technologies
35
44
.
Michael P. Eaton & Ellen M. Iannoli. (2010) Coagulation considerations for infants and children undergoing cardiopulmonary bypass. Pediatric Anesthesia 21:1, pages 31-42.
Crossref
Crossref
J. William Gaynor & Darryl H. Berkowitz. 2011. Pediatric Critical Care. Pediatric Critical Care
379
400
.
Jeffrey A. Poynter. (2010) Thromboresistant Cardiopulmonary Bypass Circuits: Room for Improvement?. Journal of Surgical Research 163:2, pages e51-e52.
Crossref
Crossref
I. Dimarakis, S.M. Rehman & G. Asimakopoulos. 2010. Biomaterials and Devices for the Circulatory System. Biomaterials and Devices for the Circulatory System
3
23
.
N. Sohn, J. Marcoux, T. Mycyk, J. Krahn & QH Meng. (2009) The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress. Perfusion 24:4, pages 231-237.
Crossref
Crossref
Kelly M. McLean, John P. Lombardi & Jeffrey M. Pearl. 2009. Cardiovascular Pediatric Critical Illness and Injury. Cardiovascular Pediatric Critical Illness and Injury
1
15
.
K. T. Lappegård, G. Bergseth, J. Riesenfeld, A. Pharo, P. Magotti, J. D. Lambris & T. E. Mollnes. (2008) The artificial surface-induced whole blood inflammatory reaction revealed by increases in a series of chemokines and growth factors is largely complement dependent. Journal of Biomedical Materials Research Part A 87A:1, pages 129-135.
Crossref
Crossref
Michael E. Jessen. (2006) Pro: Heparin-Coated Circuits Should be Used for Cardiopulmonary Bypass. Anesthesia & Analgesia 103:6, pages 1365-1369.
Crossref
Crossref
Frank H. Kern, Richard J. Ing & William J. Greeley. 2006. Smith's Anesthesia for Infants and Children. Smith's Anesthesia for Infants and Children
571
650
.
Anjo M. Draaisma & Mark G. Hazekamp. (2005) Coated versus Noncoated Circuits in Pediatric Cardiopulmonary Bypass. ASAIO Journal 51:5, pages 663-664.
Crossref
Crossref
Jodie Y. Duffy, David P. Nelson, Steven M. Schwartz, Connie J. Wagner, Steven M. Bauer, Jefferson M. Lyons, Jerri L. McNamara & Jeffrey M. Pearl. (2004) Glucocorticoids reduce cardiac dysfunction after cardiopulmonary bypass and circulatory arrest in neonatal piglets. Pediatric Critical Care Medicine 5:1, pages 28-34.
Crossref
Crossref
Jonas Andersson, Javier Sanchez, Kristina Nilsson Ekdahl, Graciela Elgue, Bo Nilsson & Rolf Larsson. (2003) Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated bloodin vitro. Journal of Biomedical Materials Research 67A:2, pages 458-466.
Crossref
Crossref
T Gourlay & P Connolly. (2016) Does cardiopulmonary bypass still represent a good investment? The biomaterials perspective. Perfusion 18:4, pages 225-231.
Crossref
Crossref
Eva Jensen, Svenerik Andréasson, Anders Bengtsson, Håkan Berggren, Rolf Ekroth, Lena Lindholm & John Ouchterlony. (2003) Influence of two different perfusion systems on inflammatory response in pediatric heart surgery. The Annals of Thoracic Surgery 75:3, pages 919-925.
Crossref
Crossref
Li-Chien Hsu. (2016) Heparin-coated cardiopulmonary bypass circuits: current status. Perfusion 16:5, pages 417-428.
Crossref
Crossref
T Gourlay. (2016) Biomaterial development for cardiopulmonary bypass. Perfusion 16:5, pages 381-390.
Crossref
Crossref
M.E. Mukadam, P. Pritchard, D. Riddington, M. Wilkes, T.R. Graham, Jay Charles Horrow & Bruce D. Spiess. (2001) Case 7—2001 Management during cardiopulmonary bypass of patients with presumed fish allergy. Journal of Cardiothoracic and Vascular Anesthesia 15:4, pages 512-519.
Crossref
Crossref